Anthem (NYSE:ANTM) had its price objective reduced by equities research analysts at Barclays from $338.00 to $316.00 in a note issued to investors on Wednesday, Marketbeat Ratings reports. The brokerage presently has an “overweight” rating on the stock. Barclays‘s price target points to a potential upside of 31.88% from the stock’s previous close.
A number of other research analysts also recently weighed in on ANTM. Zacks Investment Research raised Anthem from a “hold” rating to a “buy” rating and set a $333.00 price objective on the stock in a research note on Friday, February 1st. Stephens raised their price objective on Anthem from $310.00 to $350.00 and gave the company an “overweight” rating in a research note on Thursday, January 31st. ValuEngine downgraded Anthem from a “buy” rating to a “hold” rating in a research note on Wednesday, January 9th. Credit Suisse Group raised their price objective on Anthem from $344.00 to $368.00 and gave the company an “outperform” rating in a research note on Friday, March 8th. Finally, Argus assumed coverage on Anthem in a research note on Thursday, January 24th. They issued a “buy” rating and a $333.00 price objective on the stock. Three equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $330.60.
Shares of ANTM stock traded up $3.37 during trading on Wednesday, reaching $239.62. The company had a trading volume of 3,927,929 shares, compared to its average volume of 1,880,661. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.56 and a current ratio of 1.56. Anthem has a one year low of $219.96 and a one year high of $317.99. The company has a market capitalization of $61.24 billion, a price-to-earnings ratio of 15.08, a PEG ratio of 0.93 and a beta of 0.92.
In other Anthem news, EVP Gloria M. Mccarthy sold 7,700 shares of the firm’s stock in a transaction that occurred on Monday, February 4th. The stock was sold at an average price of $302.98, for a total value of $2,332,946.00. Following the sale, the executive vice president now owns 46,456 shares of the company’s stock, valued at approximately $14,075,238.88. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Gloria M. Mccarthy sold 7,701 shares of the firm’s stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $303.73, for a total value of $2,339,024.73. The disclosure for this sale can be found here. Insiders sold a total of 23,601 shares of company stock worth $6,862,346 in the last ninety days. Insiders own 0.17% of the company’s stock.
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Martingale Asset Management L P grew its holdings in shares of Anthem by 0.6% during the 3rd quarter. Martingale Asset Management L P now owns 153,079 shares of the company’s stock worth $41,952,000 after purchasing an additional 900 shares in the last quarter. Bridges Investment Management Inc. grew its holdings in shares of Anthem by 29.8% during the 3rd quarter. Bridges Investment Management Inc. now owns 2,176 shares of the company’s stock worth $596,000 after purchasing an additional 500 shares in the last quarter. First Heartland Consultants Inc. acquired a new stake in shares of Anthem during the 3rd quarter worth approximately $230,000. Cohen & Steers Inc. grew its holdings in shares of Anthem by 16.9% during the 3rd quarter. Cohen & Steers Inc. now owns 91,096 shares of the company’s stock worth $24,965,000 after purchasing an additional 13,139 shares in the last quarter. Finally, Beaton Management Co. Inc. acquired a new stake in shares of Anthem during the 3rd quarter worth approximately $219,000. 89.09% of the stock is currently owned by hedge funds and other institutional investors.
Anthem Company Profile
Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets.
Featured Story: How much can an individual set aside as a catch-up contribution?
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.